These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15057040)

  • 1. Comparison of in vivo anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
    Yukitake J; Otake H; Inoue S; Wakamatsu K; Ito S
    Melanoma Res; 2004 Apr; 14(2):115-20. PubMed ID: 15057040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
    Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S
    Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antimelanoma effects of 4-S-cysteaminylphenol and its homologues.
    Inoue S; Hasegawa K; Wakamatsu K; Ito S
    Melanoma Res; 1998 Apr; 8(2):105-12. PubMed ID: 9610862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol.
    Tandon M; Thomas PD; Shokravi M; Singh S; Samra S; Chang D; Jimbow K
    Biochem Pharmacol; 1998 Jun; 55(12):2023-9. PubMed ID: 9714323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect.
    Miura S; Ueda T; Jimbow K; Ito S; Fujita K
    Arch Dermatol Res; 1987; 279(4):219-25. PubMed ID: 3674957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase.
    Pankovich JM; Jimbow K; Ito S
    Pigment Cell Res; 1990 Sep; 3(3):146-9. PubMed ID: 2127097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
    Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K
    Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol.
    Hasegawa K; Ito S; Inoue S; Wakamatsu K; Ozeki H; Ishiguro I
    Biochem Pharmacol; 1997 May; 53(10):1435-44. PubMed ID: 9260870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma.
    Kitagawa M; Nemoto T; Seki S; Ito S; Kasuga T
    J Cancer Res Clin Oncol; 1993; 119(8):470-4. PubMed ID: 8099588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.
    Alena F; Jimbow K; Ito S
    Cancer Res; 1990 Jun; 50(12):3743-7. PubMed ID: 2340520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
    Miura T; Jimbow K; Ito S
    Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma.
    Jimbow K; Miura T; Ito S; Ishikawa K
    Pigment Cell Res; 1989; 2(1):34-9. PubMed ID: 2717528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy.
    Ito Y; Jimbow K
    Cancer Res; 1987 Jun; 47(12):3278-84. PubMed ID: 3107807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of cysteaminylphenols on human melanoma cells in vivo and in vitro: 4-S-cysteaminylphenol binds protein disulphide isomerase.
    Parsons PG; Favier D; McEwan M; Takahashi H; Jimbow K; Ito S
    Melanoma Res; 1991; 1(2):97-104. PubMed ID: 1823629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
    Gili A; Thomas PD; Ota M; Jimbow K
    Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-mediated apoptosis.
    Minamitsuji Y; Toyofuku K; Sugiyama S; Yamada K; Jimbow K
    J Investig Dermatol Symp Proc; 1999 Sep; 4(2):130-6. PubMed ID: 10536987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kD) binding glycoprotein.
    Yamada K; Jimbow K
    Melanoma Res; 1992 Nov; 2(4):225-33. PubMed ID: 1490110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol.
    Prezioso JA; Wang N; Bloomer WD
    Cancer Chemother Pharmacol; 1992; 30(5):394-400. PubMed ID: 1505078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues.
    Inoue S; Ito S; Wakamatsu K; Jimbow K; Fujita K
    Biochem Pharmacol; 1990 Mar; 39(6):1077-83. PubMed ID: 2108682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.